Captrust Financial Advisors Haemonetics Corp Transaction History
Captrust Financial Advisors
- $30 Billion
- Q1 2024
A detailed history of Captrust Financial Advisors transactions in Haemonetics Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 3,204 shares of HAE stock, worth $279,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,204
Previous 6,557
51.14%
Holding current value
$279,004
Previous $560,000
51.25%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding HAE
# of Institutions
311Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Capital Research Global Investors Los Angeles, CA6.67MShares$581 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.98MShares$521 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$470 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$372 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$330 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.47B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...